hematoxylin has been researched along with Cicatrix, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Li, S; Sun, J; Yang, J | 1 |
| Lu, SL; Song, F; Wang, XQ; Zheng, J | 1 |
2 other study(ies) available for hematoxylin and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts.
Topics: Animals; Antioxidants; Apoptosis; Cicatrix, Hypertrophic; Eosine Yellowish-(YS); Fibroblasts; Hematoxylin; Humans; Mesenchymal Stem Cells; Mice; Mice, Nude; NF-E2-Related Factor 2; Reactive Oxygen Species | 2022 |
Dynamic hypoxia in scar tissue during human hypertrophic scar progression.
Topics: Adolescent; Adult; Antigens, CD34; Blood Gas Monitoring, Transcutaneous; Cell Hypoxia; Cicatrix, Hypertrophic; Coloring Agents; Disease Progression; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Hypoxia-Inducible Factor 1; Male; Microvessels; Middle Aged; Oxygen; Staining and Labeling; Young Adult | 2014 |